AML
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.
BET protein antagonist JQ1 is synergistically lethal with <span class="gene" id="25053825-0-58-62">FLT3</span> tyrosine kinase inhibitor (TKI) and overcomes resistance to <span class="gene" id="25053825-0-123-127">FLT3</span>-TKI in <span class="disease" id="25053825-0-135-138">AML</span> cells expressing FLT-ITD.